Ischemic Heart Disease. Other acute ischemic heart diseases
Conditions
Interventions
Intervention 1: Intervention group: Valsartan (Arena company) treatment once a day for 6 months. Intervention 2: Intervention group: Treatment with sacubitril valsartan (Arena company) once a day for
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Consent to participate in the study Heart failure patients with LVEF less than 40 Coronary Artery Disease History of angioplasty Coronary artery bypass surgery
Exclusion criteria
Exclusion criteria: Insulin-dependent diabetes mellitus respiratory diseases Chronic kidney diseases Uncontrolled blood pressure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Left Ventricular Ejection Fraction. Timepoint: Before and after 6 months of intervention. Method of measurement: Echocardiography.;Left ventricular end-diastolic volume. Timepoint: Before and after 6 months of intervention. Method of measurement: Echocardiography.;Left Ventricular End-Systolic Volume. Timepoint: Before and after 6 months of intervention. Method of measurement: Echocardiography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospitalization. Timepoint: After 6 months of intervention. Method of measurement: Examination of patient records.;Mortality. Timepoint: After 6 months of intervention. Method of measurement: Examination of patient records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzaneh Ahamdi
Ahvaz University of Medical Sciences
Outcome results
None listed